FIELD: medicine.
SUBSTANCE: invention relates to medicine, specifically to ophthalmology. For predicting severe uveal melanoma, a pathological examination of enucleated tumor microenvironment is performed. If observing 6 or more mast cells and the presence of tumor cells in the lumen of at least one emissary, severe course of uveal melanoma is predicted.
EFFECT: method provides higher accuracy of determining severity of uveal melanoma by performing pathomorphological examination.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING THE UNFAVORABLE COURSE OF UVEAL MELANOMA ASSOCIATED WITH A MALIGNANT MICROENVIRONMENT | 2019 |
|
RU2709214C1 |
| METHOD FOR PREDICTING THE SURVIVAL CAPACITY OF PATIENTS AFTER ENUCLEATION FOR INITIAL CHOROID MELANOMA SPREAD TO THE OPTIC DISC | 2021 |
|
RU2778965C1 |
| METHOD FOR PREDICTION OF SURVIVAL RATE AFTER ENUCLEATION WITH UVEAL MELANOMA DEVELOPED TO EQUATOR | 2024 |
|
RU2822319C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF MORPHOLOGICAL FORMS OF UVEAL MELANOMA | 2014 |
|
RU2577237C1 |
| METHOD FOR PREDICTION OF UNFAVORABLE COURSE OF INITIAL CHOROID MELANOMA AFTER ORGAN-PRESERVING TREATMENT, BASED ON DETERMINATION OF LEVEL OF TRANSFORMING GROWTH FACTOR TGF-β2 | 2020 |
|
RU2733577C1 |
| METHOD FOR DETECTING AN INFLAMMATORY COMPONENT THAT PROMOTES TUMOR GROWTH IN INITIAL CHOROIDAL MELANOMA | 2020 |
|
RU2748528C1 |
| METHOD FOR PREDICTING CLINICAL COURSE OF UVEAL MELANOMA DEVELOPMENT | 2001 |
|
RU2197731C2 |
| METHOD FOR PREDICTING CLINICAL FLOW OF UVEAL MELANOMA | 2001 |
|
RU2193200C1 |
| METHOD PREDICTING CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER p53 | 2002 |
|
RU2208789C1 |
| METHOD OF PREDICTION OF CLINICAL COURSE OF UVEA MELANOMA BASED ON APOPTHOSIS MARKER Bax | 2002 |
|
RU2208790C1 |
